Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
7.94M
-
Shares change
-
+916K
-
Total reported value, excl. options
-
$77.2M
-
Value change
-
+$9.82M
-
Put/Call ratio
-
1.17
-
Number of buys
-
42
-
Number of sells
-
-35
-
Price
-
$9.73
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q3 2021
108 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q3 2021.
Co-Diagnostics, Inc. - Common Stock (CODX) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.94M shares
of 38.5M outstanding shares and own 20.6% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.8M shares), MILLENNIUM MANAGEMENT LLC (754K shares), BlackRock Inc. (531K shares), Parametric Portfolio Associates LLC (526K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (424K shares), Russell Investments Group, Ltd. (333K shares), Advisor Resource Council (296K shares), GEODE CAPITAL MANAGEMENT, LLC (256K shares), MARSHALL WACE, LLP (221K shares), and RENAISSANCE TECHNOLOGIES LLC (185K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.